D
LENZ Therapeutics, Inc. LENZ
$28.00 $0.692.53% NASDAQ
Recommendation
Prev Close
$27.31
Volume
911,840
Avg Vol (90D)
876,479
Market Cap
$854.53M
Dividend & Yield
--
52-Week Range
$16.54 - $50.40
P/E (TTM)
--
EPS (TTM)
-$2.11
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
LENZ Therapeutics (NASDAQ:LENZ) Shares Down 6.1% - Here's What Happened
12/3/2025 - MarketBeat
Skandinaviska Enskilda Banken AB publ Acquires New Stake in LENZ Therapeutics, Inc. $LENZ
12/3/2025 - MarketBeat
Geode Capital Management LLC Grows Stock Position in LENZ Therapeutics, Inc. $LENZ
12/3/2025 - MarketBeat
Lotus submits NDA for VIZZ in South Korea to treat presbyopia
12/2/2025 - Pharmaceutical Business Review
Lenz Therapeutics announces MFDS submission of NDA for LNZ100
12/1/2025 - The Fly
LENZ Therapeutics Announces MFDS Submission of New Drug Application for LNZ100 (VIZZ ) in South Korea for the Treatment of Presbyopia
12/1/2025 - Globe Newswire
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives $56.40 Consensus Target Price from Brokerages
11/29/2025 - Ticker Report
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.3% - Here's What Happened
11/26/2025 - MarketBeat
LENZ Therapeutics to Present at Upcoming Investor Conferences
11/25/2025 - GuruFocus
LENZ Therapeutics to Present at Upcoming Investor Conferences
11/25/2025 - Globe Newswire
LENZ Therapeutics (LENZ, $31.94) price may drop as it broke higher Bollinger Band on Nov 24, 2025
11/25/2025 - Tickeron - Stocks
LENZ Makes Bullish Cross Above Critical Moving Average
11/24/2025 - Market News Video
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Rating of "Moderate Buy" by Brokerages
11/23/2025 - MarketBeat
Zacks Research Downgrades LENZ Therapeutics (NASDAQ:LENZ) to Hold
11/23/2025 - MarketBeat
Interesting LENZ Put And Call Options For July 2026
11/21/2025 - Stock Options Channel
LENZ Therapeutics (NASDAQ:LENZ) Insider Shawn Olsson Sells 10,000 Shares
11/21/2025 - MarketBeat
LENZ Therapeutics (NASDAQ:LENZ) Insider Shawn Olsson Sells 10,000 Shares
11/20/2025 - MarketBeat
LENZ Therapeutics (LENZ, $28.4) entered Uptrend as Momentum indicator ascends above 0 level on Nov 19, 2025
11/20/2025 - Tickeron - Stocks
Candriam S.C.A. Takes $5.02 Million Position in LENZ Therapeutics, Inc. $LENZ
11/17/2025 - MarketBeat
Calamos Advisors LLC Makes New $515,000 Investment in LENZ Therapeutics, Inc. $LENZ
11/16/2025 - MarketBeat
LENZ Therapeutics (LENZ, $26.49) Aroon Indicator entered a Downtrend on November 13, 2025.
11/14/2025 - Tickeron - Stocks
LENZ Therapeutics (LENZ, $26.49) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 13, 2025
11/14/2025 - Tickeron - Stocks
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 6% - What's Next?
11/13/2025 - MarketBeat
LENZ Therapeutics (LENZ, $25.5) Aroon Indicator entered a Downtrend on November 12, 2025.
11/13/2025 - Tickeron - Stocks
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 6% - Here's What Happened
11/12/2025 - Ticker Report
Income Statement
Total Revenue (TTM)
$17.50M
EBITDA (TTM)
-$67.70M
EBIT (TTM)
-$67.90M
Net Income (TTM)
-$58.88M
Balance Sheet
Total Assets (Q)
$210.70M
Total Debt (Q)
$954.00K
Total Liabilities (Q)
$16.78M
Book Value Per Share (Q)
$6.78
Cash Flow
Cash from Operations (TTM)
-$45.22M
Cash from Investing (TTM)
$2.28M
Cash from Financing (TTM)
$27.18M
Net Change in Cash (TTM)
-$15.76M
Filings
Filing Date
Wednesday, November 5, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
--
7-Day Total Return
-5.28%
30-Day Total Return
-16.57%
60-Day Total Return
-29.81%
90-Day Total Return
-11.14%
Year to Date Total Return
-1.03%
1-Year Total Return
-21.63%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $16.54
52-week High
Oct 02, 2025 - $50.40
Valuation
Market Cap
$854.53M - Small Cap
Enterprise Value
$653.31M
Price/Sales (TTM)
44.54
Price/Book (Q)
4.03
Dividends and Shares
Shares Outstanding
28.54
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.lenz-tx.com
Phone Number
858 925 7000
Address
201 Lomas Santa Fe Drive
Solana Beach, CA 92075
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
LENZ Therapeutics, Inc. operates as a biopharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed